{"referenced_tweets": [{"type": "replied_to", "id": "1262708276225085445"}], "possibly_sensitive": false, "entities": {"hashtags": [{"start": 13, "end": 32, "tag": "Hydroxychloroquine"}, {"start": 138, "end": 150, "tag": "coronavirus"}], "mentions": [{"start": 0, "end": 12, "username": "BillOReilly", "id": "23970102"}], "urls": [{"start": 269, "end": 292, "url": "https://t.co/X7enSN1Q7G", "expanded_url": "https://www.fiercepharma.com/marketing/gilead-s-covid-19-therapy-remdesivir-worth-4-460-per-course-says-pricing-watchdog", "display_url": "fiercepharma.com/marketing/gile\u2026"}]}, "reply_settings": "everyone", "in_reply_to_user_id": "23970102", "created_at": "2020-05-19T11:53:05.000Z", "text": "@BillOReilly #Hydroxychloroquine costs &lt; $2.00 for 30 tabs.\n\nThe cost projected for Gilead\u2019s Resdimivir is $4,460.\n\nWho is running the #coronavirus drug show?\nWho\u2019s in bed with whom? \n\nFauci (NIH/CDC) gets/got MILLIONS from Gilead for hepatitis.\n\nAll about the $...\nhttps://t.co/X7enSN1Q7G", "lang": "en", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "source": "Twitter for iPad", "author_id": "63200991", "conversation_id": "1262708276225085445", "id": "1262712881822552065", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}]}